Drug Interactions between Ogivri and Propulsid
This report displays the potential drug interactions for the following 2 drugs:
- Ogivri (trastuzumab)
- Propulsid (cisapride)
Interactions between your drugs
No interactions were found between Ogivri and Propulsid. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Ogivri is in the drug class HER2 inhibitors.
- Ogivri is used to treat the following conditions:
- Propulsid is in the drug class GI stimulants.
- Propulsid is used to treat the following conditions:
Drug and food interactions
Applies to: Propulsid (cisapride)
Cisapride is no longer on the market in the US. Do not take cisapride with any other medication, food, or beverage.
**Cisapride (Propulsid) is no longer marketed in the United States. You should only be taking cisapride if you are obtaining the medication from your doctor though a Limited Access Program developed jointly by the manufacturer and the FDA.**
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.